ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
34 announcements
Jubilant Ingrevia has issued Commercial Papers worth Rs. 100 Crore. This issuance, with a 90-day tenure, falls within the previously approved Rs. 600 Crore outstanding limit.
Jubilant Ingrevia Employees Welfare Trust sold 8,807 shares worth Rs.0.56 Crore. The sale was executed to facilitate the exercise of ESOP options.
Jubilant Ingrevia Employees Welfare Trust sold 2,587 equity shares worth Rs. 0.17 Crore on September 11, 2026.
Jubilant Ingrevia Employees Welfare Trust sold 5,622 equity shares for Rs. 0.38 Crore. The transfer was executed pursuant to the exercise of ESOPs.
Jubilant Ingrevia Ltd held its 7th AGM on August 26, 2026. All proposed resolutions, including dividend declaration and director appointments, were duly passed by members.
Jubilant Ingrevia Employees Welfare Trust sold 2,627 shares valued at ₹0.19 Crore, as disclosed in a regulatory filing under PIT Regulations.
Jubilant Ingrevia Ltd will acquire a 40% strategic stake in Zettaone Technologies for ₹189.2 Crore. This investment strengthens the company's presence in the electronics design and manufacturing space.
Jubilant Ingrevia informed shareholders with unregistered emails about accessing the Annual Report and AGM notice for FY 2025-26 via the company website.
Jubilant Ingrevia has submitted its Business Responsibility and Sustainability Report (BRSR) for the Financial Year 2025-26 as per SEBI regulations.
Jubilant Ingrevia Ltd has scheduled its 7th Annual General Meeting for August 26, 2026. The meeting agenda includes dividend declaration and re-appointment of directors.
Jubilant Ingrevia reported a strong Q1 FY27 with revenue at a 15-quarter high of INR 1,300 Cr (up 25% YoY). Strategy focuses on the 'Pinnacle' journey, expanding CDMO and Specialty Chemical pipelines.
Jubilant Ingrevia Ltd reported revenue from operations of ₹1,300 Cr (+25.2% YoY) and net profit of ₹106 Cr (+41.3% YoY) for Q1 FY27.
Jubilant Ingrevia Ltd reported revenue from operations of ₹1,300 Cr (+25.3% YoY) and net profit of ₹105.8 Cr (+40.9% YoY) for Q1 FY27.
Jubilant Ingrevia has granted 42,298 stock options to eligible employees. These include both Restricted Stock Units and Performance Linked Stock Units.
Jubilant Ingrevia scheduled a board meeting for July 22, 2026. The board will consider standalone and consolidated financial results for the quarter ended June 30, 2026.
Jubilant Ingrevia received a favourable tax order setting aside a ₹0.72 Crore demand and penalty. The ruling eliminates a contingent liability from the company's books.
Jubilant Ingrevia reported highest quarterly revenue and EBITDA in 14 quarters for Q4 FY26, driven by 10% volume growth and specialty chemical momentum.
Jubilant Ingrevia reported record quarterly revenue and EBITDA in Q4FY26, driven by specialty chemicals volume growth and effective handling of Middle East disruptions.
Jubilant Ingrevia Limited appointed M/s. J.K. Kabra and Co. as Cost Auditors for a 12-month term. This routine regulatory appointment ensures statutory costing compliance and governance.
Jubilant Ingrevia Limited appointed M/s. J.K. Kabra and Co. as Cost Auditors for a 12-month term. This ensures regulatory compliance and provides specialized oversight of costing systems.
Jubilant Ingrevia reported FY26 revenue of ₹4,388 Crore with 9% EBITDA growth. The firm highlights resilient demand and strategic growth through its Pinnacle journey initiatives.
Jubilant Ingrevia recommended a 250% final dividend (Rs. 2.50 per share) for FY 2025-26. July 24, 2026 is the fixed record date for payment.
Jubilant Ingrevia Ltd reported revenue from operations of ₹1,179 Cr (+12.1% YoY) and net profit of ₹86.4 Cr (+16.8% YoY) for Q4 FY26.
Jubilant Ingrevia Limited reported consolidated annual revenue of ₹4,388.07 Crore with a net profit of ₹277.91 Crore. The Board recommended a final dividend of ₹2.5 per share.
Jubilant Ingrevia received a ₹19.87 Crore income tax assessment order for FY 2022-23. The company plans to appeal and anticipates no material adverse financial impact.
Jubilant Ingrevia Limited received an appeal order confirming a GST demand and penalty totaling approximately ₹2.04 Crore for FY 2017-18. The order relates to alleged wrong availment of transitional credit. The company intends to appeal the decision before the GSTAT and states there is no material financial impact.
Jubilant Ingrevia Limited has scheduled a board meeting for May 26, 2026. The board will consider audited standalone and consolidated financial results for the year ended March 31, 2026, and recommend a final dividend. The trading window remains closed until May 28, 2026.
Revenue flat as strong volume growth offset by persistent pricing pressures across segments. Management maintains optimism based on new CDMO capacity and ESG-driven cost savings.
Jubilant Ingrevia Limited has scheduled a Board Meeting for May 26, 2026. The directors will consider audited financial results for the quarter and year ended March 31, 2026, and a recommendation for a final dividend.
Jubilant Ingrevia Limited clarified to the BSE that it has no material unpublished price-sensitive information affecting its share price movement. The company confirmed compliance with SEBI Listing Regulations and assured continued timely disclosures of all price-sensitive events to the stock exchanges.